Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Prudential Jennison Health Sciences Fund

+ Add to Watchlist

PJHRX:US

55.83 USD 0.23 0.41%

As of 09:29:30 ET on 05/29/2015.

Snapshot for Prudential Jennison Health Sciences Fund (PJHRX)

Year To Date: +17.98% 3-Month: +7.34% 3-Year: +38.78% 52-Week Range: 36.36 - 55.99
1-Month: +9.84% 1-Year: +54.42% 5-Year: - Beta vs SPR: 0.96

Mutual Fund Chart for PJHRX

No chart data available.
  • PJHRX:US 55.83
  • 1M
  • 1Y
Interactive PJHRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PJHRX

Prudential Jennison Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of assets plus borrowings for investment purposes in securities of companies in the health sciences sector, such as pharmaceutical, biotechnology and healthcare service providers.

Inception Date: 02-03-2012 Telephone: 1-800-225-1852
Managers: DAVID CHAN / MICHAEL DEL BALSO
Web Site: www.prudentialfunds.com

Fundamentals for PJHRX

NAV (on 2015-05-29) 55.83
Assets (M) (on 2015-05-29) 3,804.73
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for PJHRX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-23) 1.84
Dividend Yield (ttm) 12.38

Fees & Expenses for PJHRX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.72
Redemption Fee 0.00
12b1 Fee 0.75
Expense Ratio 1.35

Top Fund Holdings for PJHRX

Filing Date: 04/30/2015
Name Position Value % of Total
BioMarin Pharmaceutical Inc 1,752,708 196,390,931 5.704%
Shire PLC 581,006 141,480,771 4.109%
Actavis plc 459,137 129,871,492 3.772%
Incyte Corp 1,287,134 125,057,939 3.632%
Biogen Inc 275,374 102,970,600 2.991%
Intercept Pharmaceuticals Inc 383,706 97,004,714 2.817%
Celgene Corp 876,811 94,748,197 2.752%
Medtronic PLC 1,202,137 89,499,100 2.599%
Alnylam Pharmaceuticals Inc 787,111 80,182,998 2.329%
AstraZeneca PLC 1,150,144 78,761,861 2.288%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil